1. Medtech Insight
  2. >>Geography
  3. >>Europe

As Digital Medtech Innovations Speed Ahead, How Can The UK Regulator Keep Up?

 
• By Eliza Slawther

Digital health technologies are evolving rapidly, but UK regulation is lagging behind. Using international standards “as default” could go some way to closing this gap, according to a report by UK medtech trade body ABHI.

Losing Race
• Source: Shutterstock

The UK is edging closer to finalizing its regulatory sovereignty from the EU, but success will depend on its ability to keep pace with rapid medtech developments, such as those driven by artificial intelligence (AI).

The Association of British HealthTech Industries (ABHI) warns in a recent report that the “process of initial and ongoing approval, and of post-market surveillance, needs to reflect the rapid pace...

International harmonized standards should be the “default approach” taken to address gaps in the regulatory regime, rather than legislation, the ABHI report says. This is because these documents “can evolve...

More from Europe

More from Geography

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.